Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-15
DOI
10.3389/fonc.2020.00798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data
- (2020) Marta B. Lopes et al. BMC BIOINFORMATICS
- Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
- (2020) Ella L. Kim et al. Cancers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Intra-Tumor DNA Methylation Heterogeneity in Glioblastoma; Implications for DNA Methylation-Based Classification
- (2019) Anna Wenger et al. NEURO-ONCOLOGY
- Prognostic Gene Discovery in Glioblastoma Patients using Deep Learning
- (2019) Kelvin Wong et al. Cancers
- A Review on a Deep Learning Perspective in Brain Cancer Classification
- (2019) Gopal S. Tandel et al. Cancers
- Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
- (2019) Paul Daniel et al. Frontiers in Oncology
- Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
- (2019) Paul Lesueur et al. BMC CANCER
- Atlas of RNA sequencing profiles for normal human tissues
- (2019) Maria Suntsova et al. Scientific Data
- Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
- (2019) Massimo Romani et al. Cancers
- New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets
- (2019) Nicolas Borisov et al. Frontiers in Oncology
- Bioinformatics of nanopore sequencing
- (2019) Wojciech Makałowski et al. JOURNAL OF HUMAN GENETICS
- Do no harm: a roadmap for responsible machine learning for health care
- (2019) Jenna Wiens et al. NATURE MEDICINE
- An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis
- (2019) Po-Hsuan Cameron Chen et al. NATURE MEDICINE
- Discovering Rare Genes Contributing to Cancer Stemness and Invasive Potential by GBM Single-Cell Transcriptional Analysis
- (2019) Lin Pang et al. Cancers
- A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency
- (2018) Nicolas Borisov et al. CELL CYCLE
- Information-Based Medicine in Glioma Patients: A Clinical Perspective
- (2018) Joeky Tamba Senders et al. Computational and Mathematical Methods in Medicine
- Next-generation sequencing in drug development: target identification and genetically stratified clinical trials
- (2018) Abolfazl Doostparast Torshizi et al. DRUG DISCOVERY TODAY
- Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma
- (2018) Rajendra P. Pangeni et al. Epigenetics
- Current and emerging EGFR therapies for glioblastoma
- (2018) Stefan Alexandru Artene et al. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- Tumor treating fields: a new approach to glioblastoma therapy
- (2018) Jonathan Rick et al. JOURNAL OF NEURO-ONCOLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Nanopore sequencing and assembly of a human genome with ultra-long reads
- (2018) Miten Jain et al. NATURE BIOTECHNOLOGY
- Temozolomide-associated hypermutation in gliomas
- (2018) Serah Choi et al. NEURO-ONCOLOGY
- Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
- (2018) Benjamin M Ellingson et al. NEURO-ONCOLOGY
- Using genomics to guide treatment for glioblastoma
- (2018) Jacob S Young et al. PHARMACOGENOMICS
- Chromatin remodeling factor BRG1 regulates stemness and chemosensitivity of glioma initiating cells
- (2018) Debolina Ganguly et al. STEM CELLS
- Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
- (2018) Nathalie E. Synhaeve et al. Acta Neuropathologica Communications
- Epigenetic Targeting of Glioblastoma
- (2018) Massimo Romani et al. Frontiers in Oncology
- Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms
- (2018) Ming-Zhu Jin et al. Frontiers in Oncology
- Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats
- (2017) Masoud Movassaghi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
- (2017) Katherine B. Peters et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
- (2017) Evanthia Galanis et al. NEURO-ONCOLOGY
- Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
- (2017) Khalil Abou-El-Ardat et al. NEURO-ONCOLOGY
- Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
- (2017) Ashley Ghiaseddin et al. ONCOLOGIST
- The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection
- (2017) Andrea M. Muscat et al. Oncotarget
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
- (2017) Spyros Darmanis et al. Cell Reports
- Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
- (2017) Maria J. Williams et al. Frontiers in Oncology
- The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells
- (2017) Hiroaki Hiramatsu et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models
- (2016) Josephine Kam Tai Dermawan et al. CANCER RESEARCH
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- (2016) Shinichi Watanabe et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
- (2016) Caroline Happold et al. JOURNAL OF CLINICAL ONCOLOGY
- Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF‐ and EGF‐driven gliomas
- (2016) Sören Müller et al. Molecular Systems Biology
- DNA methylation on N6-adenine in mammalian embryonic stem cells
- (2016) Tao P. Wu et al. NATURE
- Towards precision medicine
- (2016) Euan A. Ashley NATURE REVIEWS GENETICS
- Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma
- (2016) Tara A. Barone et al. NEURO-ONCOLOGY
- Big data visualization identifies the multidimensional molecular landscape of human gliomas
- (2016) Hamid Bolouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
- (2016) Seung Ah Choi et al. Oncotarget
- Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma
- (2016) Nicole R. Parker et al. Scientific Reports
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Adenine methylation in eukaryotes: Apprehending the complex evolutionary history and functional potential of an epigenetic modification
- (2015) Lakshminarayan M. Iyer et al. BIOESSAYS
- Spatiotemporal Evolution of the Primary Glioblastoma Genome
- (2015) Jinkuk Kim et al. CANCER CELL
- Machine Learning in Medicine
- (2015) R. C. Deo CIRCULATION
- Understanding next generation sequencing in oncology: A guide for oncologists
- (2015) Sing Yu Moorcraft et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
- (2015) Andra V. Krauze et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
- (2015) H. Ian Robins et al. JOURNAL OF NEURO-ONCOLOGY
- Circulating biomarkers for gliomas
- (2015) Manfred Westphal et al. Nature Reviews Neurology
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
- (2015) Jean-Michel Lemée et al. NEURO-ONCOLOGY
- Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
- (2015) Mona Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioma
- (2015) Michael Weller et al. Nature Reviews Disease Primers
- The evolution of nanopore sequencing
- (2015) Yue Wang et al. Frontiers in Genetics
- Genetics and epigenetics of gliomas
- (2015) M Suvà SWISS MEDICAL WEEKLY
- Next generation sequencing technology: Advances and applications
- (2014) H.P.J. Buermans et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions
- (2014) Hao Wu et al. CELL
- Perspectives for immunotherapy in glioblastoma treatment
- (2014) Gaetano Finocchiaro et al. CURRENT OPINION IN ONCOLOGY
- A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression
- (2014) Ashley A Smith et al. Epigenetics
- Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study
- (2014) Alexander Tinchon et al. JOURNAL OF NEUROLOGY
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†
- (2014) Jack M. Su et al. NEURO-ONCOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
- (2014) J. M. Francis et al. Cancer Discovery
- Current Vaccine Trials in Glioblastoma: A Review
- (2014) Linda W. Xu et al. Journal of Immunology Research
- H3F3A K27M Mutation in Pediatric CNS Tumors
- (2013) Gerrit H. Gielen et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Predictive biomarkers in adult gliomas
- (2013) Laure Thomas et al. CURRENT OPINION IN ONCOLOGY
- Using the molecular classification of glioblastoma to inform personalized treatment
- (2013) Adriana Olar et al. JOURNAL OF PATHOLOGY
- Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis
- (2013) Y.-W. Kim et al. NEURO-ONCOLOGY
- Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme
- (2013) M. Kerkhof et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Stepping stones in DNA sequencing
- (2012) Henrik Stranneheim et al. Biotechnology Journal
- Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03
- (2012) E. Q. Lee et al. CLINICAL CANCER RESEARCH
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- DNA Methylation and Its Basic Function
- (2012) Lisa D Moore et al. NEUROPSYCHOPHARMACOLOGY
- Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
- (2012) Aaron Rulseh et al. World Journal of Surgical Oncology
- DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
- (2011) Amandine Etcheverry et al. BMC GENOMICS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
- (2011) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
- (2011) Fabio M. Iwamoto et al. NEURO-ONCOLOGY
- High-throughput DNA sequencing - concepts and limitations
- (2010) Martin Kircher et al. BIOESSAYS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Next-generation sequencing: emerging lessons on the origins of human cancer
- (2010) Gerd P Pfeifer et al. CURRENT OPINION IN ONCOLOGY
- Control and reversal of the electrophoretic force on DNA in a charged nanopore
- (2010) Binquan Luan et al. JOURNAL OF PHYSICS-CONDENSED MATTER
- Base-By-Base Ratcheting of Single Stranded DNA through a Solid-State Nanopore
- (2010) Binquan Luan et al. PHYSICAL REVIEW LETTERS
- Mesenchymal Migration as a Therapeutic Target in Glioblastoma
- (2010) Jessie Zhong et al. Journal of Oncology
- Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
- (2009) M. T. McCabe et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- MicroRNAs and cancer epigenetics: a macrorevolution
- (2009) Veronica Davalos et al. CURRENT OPINION IN ONCOLOGY
- Glioblastoma multiforme: a review of therapeutic targets
- (2009) Okezie O Kanu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Sequencing technologies — the next generation
- (2009) Michael L. Metzker NATURE REVIEWS GENETICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic mechanisms in glioblastoma multiforme
- (2009) Raman P. Nagarajan et al. SEMINARS IN CANCER BIOLOGY
- DNA methylation and the functional organization of the nuclear compartment
- (2009) Jesús Espada et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Advantages and limitations of next-generation sequencing technologies: A comparison of electrophoresis and non-electrophoresis methods
- (2008) Daniel G. Hert et al. ELECTROPHORESIS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- The potential and challenges of nanopore sequencing
- (2008) Daniel Branton et al. NATURE BIOTECHNOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct genomic signatures of adaptation in pre- and postnatal environments during human evolution
- (2008) M. Uddin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now